SOPHiA GENETICS S.A. ( SOPH) - Stock Earnings
SOPH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -19.2 million USD | 21.7 million USD |
| 2026Q1 | -19.3 million USD | 21.7 million USD |
| 2026Q2 | -22.4 million USD | 23.3 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
SOPH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -79.0 million USD | 62.4 million USD |
| 2024 | -62.5 million USD | 65.2 million USD |
| 2025 | -79.0 million USD | 77.3 million USD |
| 2026 Est. | — | — |
SOPH
Price: $7.87
52 week price:
Earnings Per Share: -1.16 USD
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Country: Switzerland
Volume: 4190
Market Capitalization: 696.3 million